Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06532214

Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy

Led by Nanfang Hospital, Southern Medical University · Updated on 2024-08-01

2000

Participants Needed

1

Research Sites

104 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Hepatectomy is a crucial surgical method for treating liver diseases such as liver cancer, hepatic hemangiomas, and biliary stones. Although hepatectomy has achieved significant therapeutic effects, postoperative complications remain an inevitable issue. Complications following hepatectomy include liver failure, hepatic vascular thrombosis, wound infection at the hepatic incision, and bile leakage, among others. These complications pose a serious threat to patients' health and life, and also increase the waste of medical resources and the cost of treatment. Currently, research on postoperative complications of hepatectomy mainly focuses on small sample studies from a single center, and most studies only focus on a specific complication, lacking comprehensive and systematic analysis. Therefore, it is necessary to conduct a retrospective study analysis of complications related to hepatectomy to more comprehensively and objectively understand the incidence, risk factors, prevention, and treatment of postoperative complications, providing clinical doctors with more scientific treatment plans and guidance.

CONDITIONS

Official Title

Clinical Retrospective Study Analysis of Postoperative Complications Following Hepatectomy

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients aged 18-80 years
  • Patients who underwent liver resection surgery at the participating centers
Not Eligible

You will not qualify if you...

  • Prior cancer treatments such as transarterial chemoembolization, ablation, or targeted therapy
  • Repeat liver resection surgeries
  • Presence of other malignancies
  • Concurrent end-stage diseases including active infections, respiratory failure, decompensated heart failure, and autoimmune disease exacerbations
  • Inadequate clinical data availability in medical records

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Nanfang Hospital

Guangzhou, Guangdong, China, 510515

Actively Recruiting

Loading map...

Research Team

K

Kai Wang

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here